Abstract
Up to 2.8 × 107 fibroblast-like cells displaying an abundant presence of mesenchymal stem cell (MSC) markers CD73, CD90, CD105 and a low level of HLA-I expression can be isolated from one whole human umbilical cord (UC) using a simple and highly reproducible explant culture approach. Cells derived from whole UC, similar to cells collected from separate compartments of UC, display a distinct chondrogenic and adipogenic potential. Therefore they are potential candidates for cartilage and adipose tissue engineering. Cell differentiation along the osteogenic pathway is, however, less efficient, even after the addition of 1.25-dihydroxyvitamin D3, a potent osteoinductive substance. Isolated cells are highly proliferative, tolerate cryopreservation with an average survival rate of about 75% and after thawing can be propagated further, at least over 20 population doublings before their proliferative activity begins to decline. More importantly, they synthesize numerous trophic factors including neurotrophins and factors which facilitate angiogenesis and hematopoiesis. In conclusion, cells isolated from whole UC satisfies all requirements essential for the generation of stem cell banks containing permanently available cell material for applications in the field of regenerative medicine. Nevertheless, further studies are needed to improve and adjust the methods which are already employed for adult MSC expansion and differentiation to specific properties and requirements of the primitive stem cells collected from UC. So, our data verify that the choice of individual parameters for cell propagation, such as duration of cell expansion and cell seeding density, has a substantial impact on the quality of UC-derived cell populations.
References
Friedenstein, A. J., Piatetzky-Shapiro, I. I., & Petrakova, K. V. (1966). Osteogenesis in transplants of bone marrow cells. Journal of Embryology & Experimental Morphology, 16(3), 381–390.
Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143–147.
Dennis, J. E., Merriam, A., Awadallah, A., Yoo, J. U., Johnstone, B., & Caplan, A. I. (1999). A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. Journal of Bone and Mineral Research, 14, 700–709.
Choong, P. F., Mok, P. L., Cheong, S. K., Leong, C. F., & Then, K. Y. (2007). Generating neuron-like cells from BM-derived mesenchymal stromal cells in vitro. Cytotherapy, 9(2), 170–183.
Xu, R., Jiang, X., Guo, Z., et al. (2008). Functional analysis of neuron-like cells differentiated from neural stem cells derived from bone marrow stroma cells in vitro. Cellular and Molecular Neurobiology, 28(4), 545–558.
Sun, Y., Chen, L., Hou, X. G., et al. (2007). Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chinese Medical Journal (Engl), 120(9), 771–776.
Saulnier, N., Lattanzi, W., Puglisi, M. A., et al. (2009). Mesenchymal stromal cells multipotency and plasticity: induction toward the hepatic lineage. European Review for Medical and Pharmacological Sciences, 13(1), 71–78.
Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W., & Dazzi, F. (2005). Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood, 105(7), 2821–2827.
Kode, J. A., Mukherjee, S., Joglekar, M. V., & Hardikar, A. A. (2009). Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy, 11(4), 377–391.
Siegel, G., Schäfer, R., & Dazzi, F. (2009). The immunosuppressive properties of mesenchymal stem cells. Transplantation, 87(9), 45–49.
Jones, E., & McGonagle, D. (2008). Human bone marrow mesenchymal stem cells in vivo. Rheumatology (Oxford), 47, 126–131.
Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy, 8, 315–317.
Hui, J. H., Ouyang, H. W., Hutmacher, D. W., Goh, J. C., & Lee, E. H. (2005). Mesenchymal stem cells in musculoskeletal tissue engineering: a review of recent advances in National University of Singapore. Annals of the Academy of Medicine, Singapore, 34(2), 206–212.
Kraus, K. H., & Kirker-Head, C. (2006). Mesenchymal stem cells and bone regeneration. Veterinary Surgery, 35(3), 232–242.
Mobasheri, A., Csaki, C., Clutterbuck, A. L., Rahmanzadeh, M., & Shakibaei, M. (2009). Mesenchymal stem cells in connective tissue engineering and regenerative medicine: applications in cartilage repair and osteoarthritis therapy. Histology and Histopathology, 24(3), 347–366.
Syková, E., Jendelová, P., Urdzíková, L., Lesný, P., & Hejcl, A. (2006). Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair. Cellular and Molecular Neurobiology, 26(7-8), 1113–1129.
Perin E. (2004). Transendocardial injection of autologous mononuclear bone marrow cells in end-stage ischemic heart failure patients: one-year follow-up. International Journal of Cardiology, 95(Suppl 1), S45–S46.
Stamm, C., Kleine, H. D., Westphal, B., et al. (2004). CABG and bone marrow stem cell transplantation after myocardial infarction. Thoracic and Cardiovascular Surgeon, 52(3), 152–158.
Lazarus, H. M., Koc, O. N., Devine, S. M., et al. (2005). Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biology of Blood and Marrow Transplantation, 11(5), 389–398.
Fouillard, L., Chapel, A., Bories, D., et al. (2007). Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation. Leukemia, 21(3), 568–570.
Horwitz, E. M., Prockop, D. J., Gordon, P. L., et al. (2001). Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood, 97(5), 1227–1231.
Le Blanc, K., Rasmusson, I., Sundberg, B., et al. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 363(9419), 1439–1441.
Ringdén, O., Uzunel, M., Rasmusson, I., et al. (2006). Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation, 81(10), 1390–1397.
Majumdar, M. K., Thiede, M. A., Haynesworth, S. E., Bruder, S. P., & Gerson, S. L. (2000). Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. Journal of Hematotherapy & Stem Cell Research, 9(6), 841–848.
Caplan, A. I., & Dennis, J. E. (2006). Mesenchymal stem cells as trophic mediators. Journal of Cellular Biochemistry, 98(5), 1076–1084.
Lda Meirelles, S., Fontes, A. M., Covas, D. T., & Caplan, A. I. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine & Growth Factor Reviews, 20(5-6), 419–427.
Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411), 143–147.
Caplan, A. I. (2009). Why are MSCs therapeutic? New data: new insight. The Journal of Pathology, 217(2), 318–324.
Kuo, C. K., Li, W. J., Mauck, R. L., & Tuan, R. S. (2006). Cartilage tissue engineering: its potential and uses. Current Opinion in Rheumatology, 18(1), 64–73.
da Silva Meirelles, L., Chagastelles, P. C., & Nardi, N. B. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. Journal of Cell Science, 119(Pt 11), 2204–2213.
Marcus, A. J., & Woodbury, D. (2008). Fetal stem cells from extra-embryonic tissues: do not discard. Journal of Cellular and Molecular Medicine, 12(3), 730–742.
Baksh, D., Yao, R., & Tuan, R. S. (2007). Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells, 25, 1384–1392.
Can, A., & Karahuseyinoglu, S. (2007). Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells, 25(11), 2886–2895.
Weiss, M. L., & Troyer, D. L. (2008). Wharton’s jelly-derived cells are a primitive stromal cell population. Stem Cells, 26(3), 591–599.
Kita, K., Gauglitz, G. G., Phan, T. T., Herndon, D. N., Jeschke, M. G. (2009). Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev, Jul 27, [Epub ahead of print].
Covas, D. T., Siufi, J. L., Silva, A. R., & Orellana, M. D. (2003). Isolation and culture of umbilical vein mesenchymal stem cells. Brazilian Journal of Medical and Biological Research, 36, 1179–1183.
Sarugaser, R., Lickorish, D., Baksh, D., Hosseini, M. M., & Davies, J. E. (2005). Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells, 23, 220–229.
Weiss, M. L., Medicetty, S., & Bledsoe, A. R. (2006). Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells, 24(3), 781–792.
La Rocca, G., Anzalone, R., Corrao, S., et al. (2009). Isolation and characterization of Oct-4+/HLA-G + mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochemistry and Cell Biology, 131, 267–282.
Brockhoff, G. (2007). Grundlagen, Methoden und klinische Anwendungen der Durchflusszytometrie. In U. Sack, A. Tárnok, & G. Rothe (Eds.), Zelluläre Diagnostik (Vol. 1, pp. 604–646). Basel: Karger.
Majore, I., Moretti, P., Hass, R., Kasper, C. (2009). Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Signal. http://www.biosignaling.com/content/7/1/6. Accessed 20 March 2009.
Martinez, C., Hofmann, T. J., Marino, R., Dominici, M., & Horwitz, E. M. (2007). Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood, 109(10), 4245–4248.
Tsutsumi, S., Shimazu, A., Miyazaki, K., et al. (2001). Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochemical and Biophysical Research Communications, 288(2), 413–419.
Bianchi, G., Banfi, A., Mastrogiacomo, M., et al. (2003). Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Experimental Cell Research, 287(1), 98–105.
Thomson, J. A., Itskovitz-Eldor, J., Sander, S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145–1147.
Gronthos, S., Fitter, S., Diamond, P., et al. (2007). A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. Stem Cells and Development, 16(6), 953–963.
Qiao, C., Xu, W., Zhu, W., Hu, J., Qian, H., Yin, Q., et al. (2008). Human mesenchymal stem cells isolated from the umbilical cord. Cell Biology International, 32, 8–15.
Zhang, Z. Y., Teoh, S. H., Chong, M. S., Schantz, J. T., Fisk, N. M., Choolani, M. A., et al. (2009). Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells, 27, 126–137.
Raval, A., Puri, N., Rath, P. C., & Saxena, R. K. (1998). Cytokine regulation of expression of class I MHC antigens. Experimental & Molecular Medicine, 30(1), 1–13.
Wang, H. S., Hung, S. C., Peng, S. T., Huang, C. C., Wei, H. M., Guo, Y. J., et al. (2004). Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells, 22, 1330–1337.
Jo, C. H., Kim, O. S., Park, E. Y., Kim, B. J., Lee, J. H., Kang, S. B., et al. (2008). Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion. Cell and Tissue Research, 334, 423–433.
Sarugaser, R., Ennis, J., Stanford, W. L., & Davies, J. E. (2009). Isolation, propagation, and characterization of human umbilical cord perivascular cells (HUCPVCs). Methods in Molecular Biology, 482, 269–279.
Chung, C., & Burdick, J. A. (2009). Influence of three-dimensional hyaluronic acid microenvironments on mesenchymal stem cell chondrogenesis. Tissue Engineering. Part A, 15(2), 243–254.
Wu, S. C., Chang, J. K., Wang, C. K., Wang, G. J., & Ho, M. L. (2010). Enhancement of chondrogenesis of human adipose derived stem cells in a hyaluronan-enriched microenvironment. Biomaterials, 31(4), 631–640.
Diao, Y., Ma, Q., Cui, F., & Zhong, Y. (2008). Human umbilical cord mesenchymal stem cells: Osteogenesis in vivo as seed cells for bone tissue engineering. Journal of Biomedical Materials Research. Part A, 91(1), 123–131.
Hou, T., Xu, J., Wu, X., et al. (2009). Umbilical cord Wharton's Jelly: a new potential cell source of mesenchymal stromal cells for bone tissue engineering. Tissue Engineering. Part A, 15(9), 2325–2334.
Suzdal'tseva, Y. G., Burunova, V. V., Vakhrushev, I. V., Yarygin, V. N., & Yarygin, K. N. (2007). Capability of human mesenchymal cells isolated from different sources to differentiation into tissues of mesodermal origin. Bulletin of Experimental Biology and Medicine, 143, 114–121.
Girdlestone, J., Limbani, V. A., Cutler, A. J., & Navarrete, C. V. (2009). Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions. Cytotherapy, 11(6), 738–748.
Ishige, I., Nagamura-Inoue, T., Honda, M. J., et al. (2009). Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord. International Journal of Hematology, 90(2), 261–269.
Horwitz, E. M., Le Blanc, K., Dominaci, M., et al. (2005). Clarification of the nomenclature for MSC: The international society for cellular therapy position statement. Cytotherapy, 7(5), 393–395.
Suva, D., Garavaglia, G., Menetrey, J., et al. (2004). Non-hematopoietic human bone marrow contains long-lasting, pluripotential mesenchymal stem cells. Journal of Cellular Physiology, 198(1), 110–118.
Rubio, D., Garcia-Castro, J., Martín, M. C., et al. (2005). Spontaneous human adult stem cell transformation. Cancer Research, 65(8), 3035–3039.
Battiwalla, M., & Hematti, P. (2009). Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy, 11(5), 503–515.
Colter, D. C., Sekiya, I., & Prockop, D. J. (2001). Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proceedings of the National Academy of Sciences of the United States of America, 98(14), 7841–7845.
Sotiropoulou, P. A., Perez, S. A., Salagianni, M., Baxevanis, C. N., & Papamichail, M. (2006). Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells, 24(2), 462–471.
Małkowski, A., Sobolewski, K., Jaworski, S., & Bańkowski, E. (2008). TGF-beta binding in human Wharton's jelly. Molecular and Cellular Biochemistry, 311(1-2), 137–143.
Lu, L. L., Liu, Y. J., Yang, S. G., et al. (2006). Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica, 91(8), 1017–1026.
Hiroyama, T., Sudo, K., Aoki, N., et al. (2008). Human umbilical cord-derived cells can often serve as feeder cells to maintain primate embryonic stem cells in a state capable of producing hematopoietic cells. Cell Biology International, 32(1), 1–7.
Acknowledgements
The authors would like to thank Martin Pähler for the technical assistance and accomplishment of RT-PCR analysis, Dr. Johanna Walter for the help in the evaluation of Human Cytokine Antibody Array and Prof. DDr. Martijn van Griensven from the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology (Vienna, Austria) for kindly provided adipose tissue-derived MSC.
This study was supported by a grant from the German Research Foundation (Project number KA 1784/5).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Majore, I., Moretti, P., Stahl, F. et al. Growth and Differentiation Properties of Mesenchymal Stromal Cell Populations Derived from Whole Human Umbilical Cord. Stem Cell Rev and Rep 7, 17–31 (2011). https://doi.org/10.1007/s12015-010-9165-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-010-9165-y